Resistance and the management of complicated skin and skin structure infections: the role of ceftobiprole
April Barbour1, Hartmut Derendorf21GlaxoSmithKline, King of Prussia, PA, USA; 2Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USAAbstract: Antimicrobial resistant bacteria are an increasing concern due to the resulting increase in morbidity, mortality, and...
Saved in:
Main Authors: | April Barbour (Author), Hartmut Derendorf (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2010-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of delafloxacin, ceftaroline, ceftobiprole, and tigecycline for the empiric treatment of acute bacterial skin and skin structure infections: A network meta-analysis of randomized controlled trials
by: Abdullah A. Alhifany, et al.
Published: (2022) -
In Vitro Activities of Ceftobiprole, Dalbavancin, Tedizolid and Comparators against Clinical Isolates of Methicillin-Resistant <i>Staphylococcus aureus</i> Associated with Skin and Soft Tissue Infections
by: Sofia Maraki, et al.
Published: (2023) -
Role of telavancin in treatment of skin and skin structure infections
by: Joseph Bonkowski, et al.
Published: (2010) -
A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI)
by: Lala M Dunbar, et al.
Published: (2008) -
Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline
by: Wanda C Reygaert
Published: (2010)